Insights into Regulators of p53 Acetylation
Open accessThe DOI matches its Crossref record; 188 of the 189 references it cites were found in a registry or an index.
Abstract
The tumor suppressor p53 is a transcription factor that regulates the expression of dozens of target genes and diverse physiological processes. To precisely regulate the p53 network, p53 undergoes various post-translational modifications and alters the selectivity of target genes. Acetylation plays an essential role in cell fate determination through the activation of p53. Although the acetylation of p53 has been examined, the underlying regulatory mechanisms remain unclear and, thus, have attracted the interest of researchers. We herein discuss the role of acetylation in the p53 pathway, with a focus on p53 acetyltransferases and deacetylases. We also review recent findings on the regulators of these enzymes to understand the mode of p53 acetylation from a broader perspective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“13 known acetylation sites on p53 are attributable to the activity of at least six different KATs and KDACs [44,45].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [44]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
Comprehensive genomic profiles of small cell lung cancer
George, J., Lim, J. S., Jang, S. J., Cun, Y., Ozretić, L., Kong, G., Leenders, F., Lu, X., Fernández-Cuesta, L., Bosco, G., et al. (2015) · Nature · doi:10.1038/nature14664 · Cited by 2,340
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Phosphorylated CREB binds specifically to the nuclear protein CBP
Chrivia, J. C., Kwok, R. P. S., Lamb, N., Hagiwara, M., Montminy, M. R., & Goodman, R. H. (1993) · Nature · doi:10.1038/365855a0 · Cited by 2,052 · cited 1×
“response element-binding protein, respectively [21,22].”
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Chang, T.-C., Wentzel, E. A., Kent, O. A., Ramachandran, K., Mullendore, M., Lee, K. H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C. J., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.010 · Cited by 2,010
Kastenhuber, E. R., & Lowe, S. W. (2017) · Cell · doi:10.1016/j.cell.2017.08.028 · Cited by 1,906
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Morin, R. D., Mendez-Lago, M., Mungall, A. J., Goya, R., Mungall, K. L., Corbett, R. D., Johnson, N. A., Severson, T. M., Chiu, R., Field, M., et al. (2011) · Nature · doi:10.1038/nature10351 · Cited by 1,614
Kruse, J.-P., & Gu, W. (2009) · Cell · doi:10.1016/j.cell.2009.04.050 · Cited by 1,610 · cited 1×
“K120 and K164 are located in DBD, and both of these lysine residues are highly mutated in human cancer [6].”
BackgroundMutant p53 in Cancer: New Functions and Therapeutic Opportunities
Muller, P. A. J., & Vousden, K. H. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.021 · Cited by 1,545 · cited 1×
“The gene encoding p53 (also known as TP53) is frequently mutated in human cancers, including colorectal, lung, brain, liver, bladder, and esophageal cancers [1].”
BackgroundA p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
Yang, X.-J., Ogryzko, V. V., Nishikawa, J.-I., Howard, B. H., & Nakatani, Y. (1996) · Nature · doi:10.1038/382319a0 · Cited by 1,479
miR-34a repression of SIRT1 regulates apoptosis
Yamakuchi, M., Ferlito, M., & Lowenstein, C. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801613105 · Cited by 1,342
HDACs and HDAC Inhibitors in Cancer Development and Therapy
Li, Y., & Seto, E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026831 · Cited by 1,284
MDM2, MDMX and p53 in oncogenesis and cancer therapy
Wade, M., Li, Y.-C., & Wahl, G. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3430 · Cited by 1,279 · cited 1×
“Furthermore, a dysfunctional p53 pathway has also been detected in cancers that retain wild-type p53 due to various causes [2,3].”
BackgroundDevelopmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice
Cheng, H.-L., Mostoslavsky, R., Saito, S., Manis, J. P., Gu, Y., Patel, P., Bronson, R., Appella, E., Alt, F. W., & Chua, K. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934713100 · Cited by 1,095
Eckner, R., Ewen, M. E., Newsome, D., Gerdes, M., DeCaprio, J. A., Lawrence, J. B., & Livingston, D. M. (1994) · Genes & Development · doi:10.1101/gad.8.8.869 · Cited by 1,045
Involvement of the TIP60 Histone Acetylase Complex in DNA Repair and Apoptosis
Ikura, T., Ogryzko, V. V., Grigoriev, M., Groisman, R., Wang, J., Horikoshi, M., Scully, R., Qin, J., & Nakatani, Y. (2000) · Cell · doi:10.1016/s0092-8674(00)00051-9 · Cited by 1,029
Inactivating mutations of acetyltransferase genes in B-cell lymphoma
Pasqualucci, L., Dominguez-Sola, D., Chiarenza, A., Fabbri, G., Grunn, A., Trifonov, V., Kasper, L. H., Lerach, S., Tang, H., Ma, J., et al. (2011) · Nature · doi:10.1038/nature09730 · Cited by 949
Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence
Langley, E. (2002) · The EMBO Journal · doi:10.1093/emboj/21.10.2383 · Cited by 860
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
Pearson, M., Carbone, R., Sebastiani, C., Cioce, M., Fagioli, M., Saito, S., Higashimoto, Y., Appella, E., Minucci, S., Pandolfi, P. P., et al. (2000) · Nature · doi:10.1038/35018127 · Cited by 847
Acetylation Is Indispensable for p53 Activation
Tang, Y., Zhao, W., Chen, Y., Zhao, Y., & Gu, W. (2008) · Cell · doi:10.1016/j.cell.2008.03.025 · Cited by 838
Deacetylation of p53 modulates its effect on cell growth and apoptosis
Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. (2000) · Nature · doi:10.1038/35042612 · Cited by 818
Kim, H.-S., Patel, K., Muldoon-Jacobs, K., Bisht, K. S., Aykin-Burns, N., Pennington, J. D., van der Meer, R., Nguyen, P., Savage, J., Owens, K. M., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.11.023 · Cited by 785
SIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1α Destabilization
Finley, L. W. S., Carracedo, A., Lee, J., Souza, A., Egia, A., Zhang, J., Teruya-Feldstein, J., Moreira, P. I., Cardoso, S. M., Clish, C. B., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.014 · Cited by 782
Borrow, J., Stanton, V. P., Andresen, J. M., Becher, R., Behm, F. G., Chaganti, R. S. K., Civin, C. I., Disteche, C., Dubé, I., Frischauf, A. M., et al. (1996) · Nature Genetics · doi:10.1038/ng0996-33 · Cited by 771
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder
Gui, Y., Guo, G., Huang, Y., Hu, X., Tang, A., Gao, S., Wu, R., Chen, C., Li, X., Zhou, L., et al. (2011) · Nature Genetics · doi:10.1038/ng.907 · Cited by 747
A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM
Sun, Y., Jiang, X., Chen, S., Fernandes, N., & Price, B. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504211102 · Cited by 738 · cited 1×
“It is ubiquitously expressed and has been reported to play a role in various cellular processes, including gene transcription and DNA damage responses [48,49].”
BackgroundDulak, A. M., Stojanov, P., Peng, S., Lawrence, M. S., Fox, C., Stewart, C., Bandla, S., Imamura, Y., Schumacher, S. E., Shefler, E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2591 · Cited by 735
Tip60-Dependent Acetylation of p53 Modulates the Decision between Cell-Cycle Arrest and Apoptosis
Tang, Y., Luo, J., Zhang, W., & Gu, W. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.11.021 · Cited by 727
Binding and modulation of p53 by p300/CBP coactivators
Lill, N. L., Grossman, S. R., Ginsberg, D., DeCaprio, J., & Livingston, D. M. (1997) · Nature · doi:10.1038/42981 · Cited by 693
Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis
D'Orazi, G., Cecchinelli, B., Bruno, T., Manni, I., Higashimoto, Y., Saito, S., Gostissa, M., Coen, S., Marchetti, A., Del Sal, G., et al. (2002) · Nature Cell Biology · doi:10.1038/ncb714 · Cited by 681
Recruitment of p300/CBP in p53-Dependent Signal Pathways
Avantaggiati, M. L., Ogryzko, V., Gardner, K., Giordano, A., Levine, A. S., & Kelly, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80304-9 · Cited by 669
Tumor Suppressor HIC1 Directly Regulates SIRT1 to Modulate p53-Dependent DNA-Damage Responses
Chen, W. Y., Wang, D. H., Yen, R. C., Luo, J., Gu, W., & Baylin, S. B. (2005) · Cell · doi:10.1016/j.cell.2005.08.011 · Cited by 648
Iyer, N. G., Özdag, H., & Caldas, C. (2004) · Oncogene · doi:10.1038/sj.onc.1207118 · Cited by 638
CREBBP mutations in relapsed acute lymphoblastic leukaemia
Mullighan, C. G., Zhang, J., Kasper, L. H., Lerach, S., Payne-Turner, D., Phillips, L. A., Heatley, S. L., Holmfeldt, L., Collins-Underwood, J. R., Ma, J., et al. (2011) · Nature · doi:10.1038/nature09727 · Cited by 637
Sirtuins in aging and age-related disease
Longo, V. D., & Kennedy, B. K. (2006) · Cell · doi:10.1016/j.cell.2006.07.002 · Cited by 628
Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2
Hofmann, T. G., Möller, A., Sirma, H., Zentgraf, H., Taya, Y., Dröge, W., Will, H., & Schmitz, M. L. (2002) · Nature Cell Biology · doi:10.1038/ncb715 · Cited by 592
Mutations truncating the EP300 acetylase in human cancers
Gayther, S. A., Batley, S. J., Linger, L., Bannister, A., Thorpe, K., Chin, S.-F., Daigo, Y., Russell, P., Wilson, A., Sowter, H. M., et al. (2000) · Nature Genetics · doi:10.1038/73536 · Cited by 587
p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2
Ito, A., Lai, C.-H., Zhao, X., Saito, S., Hamilton, M. H., Appella, E., & Yao, T.-P. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1331 · Cited by 582
The transcriptional role of PML and the nuclear body
Zhong, S., Salomoni, P., & Pandolfi, P. P. (2000) · Nature Cell Biology · doi:10.1038/35010583 · Cited by 577
HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle
Deardorff, M. A., Bando, M., Nakato, R., Watrin, E., Itoh, T., Minamino, M., Saitoh, K., Komata, M., Katou, Y., Clark, D., et al. (2012) · Nature · doi:10.1038/nature11316 · Cited by 577
MDM2–HDAC1-mediated deacetylation of p53 is required for its degradation
Ito, A., Kawaguchi, Y., Lai, C., Kovacs, J. J., Higashimoto, Y., Appella, E., & Yao, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf616 · Cited by 570 · cited 1×
“HDAC1 deacetylates p53 at the K320, K373, and K382 residues [119].”
BackgroundInduction of HDAC2 expression upon loss of APC in colorectal tumorigenesis
Zhu, P., Martin, E., Mengwasser, J., Schlag, P., Janssen, K.-P., & Göttlicher, M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00114-x · Cited by 525
Transcriptional regulation by p53: one protein, many possibilities
Laptenko, O., & Prives, C. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401916 · Cited by 505
DBC1 is a negative regulator of SIRT1
Kim, J.-E., Chen, J., & Lou, Z. (2008) · Nature · doi:10.1038/nature06500 · Cited by 505
Posttranslational Modification of p53: Cooperative Integrators of Function
Meek, D. W., & Anderson, C. W. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000950 · Cited by 483
Weichert, W., Röske, A., Gekeler, V, Beckers, T., Stephan, C., Jung, K., Fritzsche, F. R., Niesporek, S., Denkert, C., Dietel, M., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604199 · Cited by 477
Negative regulation of the deacetylase SIRT1 by DBC1
Zhao, W., Kruse, J.-P., Tang, Y., Jung, S. Y., Qin, J., & Gu, W. (2008) · Nature · doi:10.1038/nature06515 · Cited by 466
Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression
Wang, S.-J., Li, D., Ou, Y., Jiang, L., Chen, Y., Zhao, Y., & Gu, W. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.022 · Cited by 462
Hilfiker, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.8.2054 · Cited by 459
E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators
Arany, Z. (1994) · Cell · doi:10.1016/0092-8674(94)90127-9 · Cited by 444 · cited 1×
“These two proteins have highly conserved regions and show 63% homology at the amino-acid level [23].”
BackgroundSIRT1 Is Significantly Elevated in Mouse and Human Prostate Cancer
Huffman, D. M., Grizzle, W. E., Bamman, M. M., Kim, J.-S., Eltoum, I. A., Elgavish, A., & Nagy, T. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0085 · Cited by 430
p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3
Wales, M. M., Biel, M. A., Deiry, W. E., Nelkin, B. D., Issa, J.-P., Cavenee, W. K., Kuerbitz, S. J., & Baylin, S. B. (1995) · Nature Medicine · doi:10.1038/nm0695-570 · Cited by 421
Clonal selection drives genetic divergence of metastatic medulloblastoma
Wu, X., Northcott, P. A., Dubuc, A., Dupuy, A. J., Shih, D. J. H., Witt, H., Croul, S., Bouffet, E., Fults, D. W., Eberhart, C. G., et al. (2012) · Nature · doi:10.1038/nature10825 · Cited by 407
Bradbury, C. A., Khanim, F. L., Hayden, R., Bunce, C. M., White, D. A., Drayson, M. T., Craddock, C., & Turner, B. M. (2005) · Leukemia · doi:10.1038/sj.leu.2403910 · Cited by 404
Active Regulator of SIRT1 Cooperates with SIRT1 and Facilitates Suppression of p53 Activity
Kim, E.-J., Kho, J.-H., Kang, M.-R., & Um, S.-J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.08.030 · Cited by 389
The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300
Patel, D., Huang, S., Baglia, L. A., & McCance, D. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.18.5061 · Cited by 374
Weichert, W., Röske, A., Niesporek, S., Noske, A., Buckendahl, A.-C., Dietel, M., Gekeler, V., Boehm, M., Beckers, T., & Denkert, C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0990 · Cited by 361
A Viral Mechanism for Inhibition of p300 and PCAF Acetyltransferase Activity
Chakravarti, D., Ogryzko, V., Kao, H.-Y., Nash, A., Chen, H., Nakatani, Y., & Evans, R. M. (1999) · Cell · doi:10.1016/s0092-8674(00)80552-8 · Cited by 339
p53 Acetylation: Regulation and Consequences
Reed, S., & Quelle, D. (2014) · Cancers · doi:10.3390/cancers7010030 · Cited by 332
Lin, Z., Yang, H., Kong, Q., Li, J., Lee, S.-M., Gao, B., Dong, H., Wei, J., Song, J., Zhang, D. D., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.03.024 · Cited by 315
hMOF Histone Acetyltransferase Is Required for Histone H4 Lysine 16 Acetylation in Mammalian Cells
Taipale, M., Rea, S., Richter, K., Vilar, A., Lichter, P., Imhof, A., & Akhtar, A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6798-6810.2005 · Cited by 312
Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy
Yue, X., Zhao, Y., Xu, Y., Zheng, M., Feng, Z., & Hu, W. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.03.030 · Cited by 308
p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity.
Shiseki, M., Nagashima, M., Pedeux, R., Kitahama-Shiseki, M., Miura, K., Okamura, S., Onogi, H., Higashimoto, Y., Appella, E., Yokota, J., et al. (2003) · PubMed · Cited by 303
Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate
Knights, C. D., Catania, J., Giovanni, S. D., Muratoglu, S., Perez, R., Swartzbeck, A., Quong, A. A., Zhang, X., Beerman, T., Pestell, R. G., et al. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200512059 · Cited by 287
Zimmermann, H., Degenkolbe, R., Bernard, H.-U., & O’Connor, M. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6209-6219.1999 · Cited by 282
The impact of acetylation and deacetylation on the p53 pathway
Brooks, C. L., & Gu, W. (2011) · Protein & Cell · doi:10.1007/s13238-011-1063-9 · Cited by 280
The coactivator LXXLL nuclear receptor recognition motif
Savkur, R. S., & Burris, T. P. (2004) · The Journal of Peptide Research · doi:10.1111/j.1399-3011.2004.00126.x · Cited by 260
Lane, D. P., Cheok, C. F., & Lain, S. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001222 · Cited by 246
DYRK1A and DYRK3 Promote Cell Survival through Phosphorylation and Activation of SIRT1
Guo, X., Williams, J. G., Schug, T. T., & Li, X. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.102574 · Cited by 240
Function of the SIRT1 protein deacetylase in cancer
Stünkel, W., Peh, B. K., Tan, Y. C., Nayagam, V. M., Wang, X., Salto‐Tellez, M., Ni, B., Entzeroth, M., & Wood, J. (2007) · Biotechnology Journal · doi:10.1002/biot.200700087 · Cited by 235
ARID1A-mutated ovarian cancers depend on HDAC6 activity
Bitler, B. G., Wu, S., Park, P. H., Hai, Y., Aird, K. M., Wang, Y., Zhai, Y., Kossenkov, A. V., Vara-Ailor, A., Rauscher III, F. J., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3582 · Cited by 232
Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer
Chen, Y., Fu, L. L., Wen, X., Wang, X. Y., Liu, J., Cheng, Y., & Huang, J. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.14 · Cited by 228
Histone Deacetylase 6 in Health and Disease
Seidel, C., Schnekenburger, M., Dicato, M., & Diederich, M. (2015) · Epigenomics · doi:10.2217/epi.14.69 · Cited by 217
AMPK Promotes p53 Acetylation via Phosphorylation and Inactivation of SIRT1 in Liver Cancer Cells
Lee, C.-W., Wong, L. L.-Y., Tse, E. Y.-T., Liu, H.-F., Leong, V. Y.-L., Lee, J. M.-F., Hardie, D. G., Ng, I. O.-L., & Ching, Y.-P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0429 · Cited by 215
NAT 10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2
Liu, X., Tan, Y., Zhang, C., Zhang, Y., Zhang, L., Ren, P., Deng, H., Luo, J., Ke, Y., & Du, X. (2016) · EMBO reports · doi:10.15252/embr.201540505 · Cited by 214
Buurman, R., Gürlevik, E., Schäffer, V., Eilers, M., Sandbothe, M., Kreipe, H., Wilkens, L., Schlegelberger, B., Kühnel, F., & Skawran, B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.033 · Cited by 211
Moreno, D. A., Scrideli, C. A., Cortez, M. A. A., De Paula Queiroz, R., Valera, E. T., Da Silva Silveira, V., Yunes, J. A., Brandalise, S. R., & Tone, L. G. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08301.x · Cited by 208
Matsuzawa, S.-I. (1998) · The EMBO Journal · doi:10.1093/emboj/17.10.2736 · Cited by 203
Li, X., Corsa, C. A. S., Pan, P. W., Wu, L., Ferguson, D., Yu, X., Min, J., & Dou, Y. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00350-10 · Cited by 202
Kobet, E., Zeng, X., Zhu, Y., Keller, D., & Lu, H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12547 · Cited by 194
DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53
Nagashima, M., Shiseki, M., Miura, K., Hagiwara, K., Linke, S. P., Pedeux, R., Wang, X. W., Yokota, J., Riabowol, K., & Harris, C. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161151798 · Cited by 185
Shen, Q., Zheng, X., McNutt, M. A., Guang, L., Sun, Y., Wang, J., Gong, Y., Hou, L., & Zhang, B. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.03.007 · Cited by 177
Two Mammalian MOF Complexes Regulate Transcription Activation by Distinct Mechanisms
Li, X., Wu, L., Corsa, C. A. S., Kunkel, S., & Dou, Y. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.07.031 · Cited by 176
Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma
Mithraprabhu, S., Kalff, A., Chow, A., Khong, T., & Spencer, A. (2014) · Epigenetics · doi:10.4161/15592294.2014.983367 · Cited by 175
Chen, R., Liu, Y., Zhuang, H., Yang, B., Hei, K., Xiao, M., Hou, C., Gao, H., Zhang, X., Jia, C., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx600 · Cited by 174
HDAC2 mediates therapeutic resistance of pancreatic cancer cells via the BH3-only protein NOXA
Fritsche, P., Seidler, B., Schüler, S., Schnieke, A., Göttlicher, M., Schmid, R. M., Saur, D., & Schneider, G. (2009) · Gut · doi:10.1136/gut.2009.180711 · Cited by 167
Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer
Fritzsche, F. R., Weichert, W., Röske, A., Gekeler, V., Beckers, T., Stephan, C., Jung, K., Scholman, K., Denkert, C., Dietel, M., et al. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-381 · Cited by 163
Insulin‐like growth factor‐1 regulates the SIRT 1‐p53 pathway in cellular senescence
Tran, D., Bergholz, J., Zhang, H., He, H., Wang, Y., Zhang, Y., Li, Q., Kirkland, J. L., & Xiao, Z. (2014) · Aging Cell · doi:10.1111/acel.12219 · Cited by 161
Current strategies to target p53 in cancer
Chen, F., Wang, W., & El-Deiry, W. S. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.04.031 · Cited by 158
HDAC2: a critical factor in health and disease
Krämer, O. H. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.09.007 · Cited by 157
MOZ increases p53 acetylation and premature senescence through its complex formation with PML
Rokudai, S., Laptenko, O., Arnal, S. M., Taya, Y., Kitabayashi, I., & Prives, C. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300490110 · Cited by 155
Aikawa, Y., Nguyen, L. A., Isono, K., Takakura, N., Tagata, Y., Schmitz, M. L., Koseki, H., & Kitabayashi, I. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601273 · Cited by 147
Histone deacetylase 1, 2, 6 and acetylated histone H4 in B‐ and T‐cell lymphomas
Marquard, L., Poulsen, C. B., Gjerdrum, L. M. R., Brown, P. D. N., Christensen, I. J., Jensen, P. B., Sehested, M., Johansen, P., & Ralfkiaer, E. M. (2009) · Histopathology · doi:10.1111/j.1365-2559.2009.03290.x · Cited by 144
SIRT3: Oncogene and Tumor Suppressor in Cancer
Torrens‐Mas, M., Oliver, J., Roca, P., & Sastre‐Serra, J. (2017) · Cancers · doi:10.3390/cancers9070090 · Cited by 143
Zhang, X.-H., Qin-Ma, Wu, H.-P., Khamis, M. Y., Li, Y.-H., Ma, L.-Y., & Liu, H.-M. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01782 · Cited by 143
Methyltransferase Set7/9 regulates p53 activity by interacting with Sirtuin 1 (SIRT1)
Liu, X., Wang, D., Zhao, Y., Tu, B., Zheng, Z., Wang, L., Wang, H., Gu, W., Roeder, R. G., & Zhu, W.-G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019619108 · Cited by 137
Induction of SOX4 by DNA damage is critical for p53 stabilization and function
Pan, X., Zhao, J., Zhang, W.-N., Li, H.-Y., Mu, R., Zhou, T., Zhang, H.-Y., Gong, W.-L., Yu, M., Man, J.-H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810147106 · Cited by 134
The ribosomal protein S26 regulates p53 activity in response to DNA damage
Cui, D., Li, L., Lou, H., Sun, H., Ngai, S. H. O., Shao, G., & Tang, J. (2013) · Oncogene · doi:10.1038/onc.2013.170 · Cited by 128
Lv, J., Liu, H., Wang, Q., Tang, Z., Hou, L., & Zhang, B. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.235 · Cited by 126
Kang, H., Jung, J.-W., Kim, M. K., & Chung, J. H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006611 · Cited by 125
Phosphorylation of Tip60 by GSK-3 Determines the Induction of PUMA and Apoptosis by p53
Charvet, C., Wissler, M., Brauns-Schubert, P., Wang, S.-J., Tang, Y., Sigloch, F. C., Mellert, H., Brandenburg, M., Lindner, S. E., Breit, B., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.03.033 · Cited by 123
Skp2 suppresses p53-dependent apoptosis by inhibiting p300.
Kitagawa, M., Lee, S. H., & McCormick, F. (2008) · Molecules and Cells · doi:10.1016/j.molcel.2007.11.036 · Cited by 122
ING2 Regulates the Onset of Replicative Senescence by Induction of p300-Dependent p53 Acetylation
Pedeux, R., Sengupta, S., Shen, J. C., Demidov, O. N., Saito, S., Onogi, H., Kumamoto, K., Wincovitch, S., Garfield, S. H., McMenamin, M., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6639-6648.2005 · Cited by 122
Yan, P., Li, Z., Xiong, J., Geng, Z., Wei, W., Zhang, Y., Wu, G., Zhuang, T., Tian, X., Liu, Z., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110038 · Cited by 121
Mutations and Deletions of the CBP Gene in Human Lung Cancer
Kishimoto, M., Kohno, T., Okudela, K., Otsuka, A., Sasaki, H., Tanabe, C., Sakiyama, T., Hirama, C., Kitabayashi, I., Minna, J. D., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.512.11.2 · Cited by 117
Chao, C., Wu, Z., Mazur, S. J., Borges, H., Rossi, M., Lin, T., Wang, J. Y. J., Anderson, C. W., Appella, E., & Xu, Y. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00062-06 · Cited by 116
Dixit, D., Sharma, V, Ghosh, S., Mehta, V. S., & Sen, E. (2012) · Cell Death & Disease · doi:10.1038/cddis.2012.10 · Cited by 115
Liu, X., Cai, S., Zhang, C., Liu, Z., Luo, J., Xing, B., & Du, X. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky777 · Cited by 115
NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity
Li, Q., Liu, X., Jin, K., Lu, M., Zhang, C., Du, X., & Xing, B. (2017) · BMC Cancer · doi:10.1186/s12885-017-3570-4 · Cited by 109
Sirt3 inhibits hepatocellular carcinoma cell growth through reducing Mdm2-mediated p53 degradation
Zhang, Y., & Zhou, L. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.053 · Cited by 108
New p53 related genes in human tumors: significant downregulation in colon and lung carcinomas
LLeonart, M., Vidal, F., Gallardo, D., Diaz-Fuertes, M., Rojo, F., Cuatrecasas, M., López-Vicente, L., Kondoh, H., Blanco, C., Carnero, A., et al. (2006) · Oncology Reports · doi:10.3892/or.16.3.603 · Cited by 99
MST1 Promotes Apoptosis through Regulating Sirt1-dependent p53 Deacetylation
Yuan, F., Xie, Q., Wu, J., Bai, Y., Mao, B., Dong, Y., Bi, W., Ji, G., Tao, W., Wang, Y., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.182543 · Cited by 98
Adenovirus E1B 55-Kilodalton Oncoprotein Inhibits p53 Acetylation by PCAF
Liu, Y., Colosimo, A. L., Yang, X.-J., & Liao, D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5540-5553.2000 · Cited by 97
TRIM29 negatively regulates p53 via inhibition of Tip60
Sho, T., Tsukiyama, T., Sato, T. Z., Kondo, T., Cheng, J., Saku, T., Asaka, M., & Hatakeyama, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.03.018 · Cited by 94
HIPK2 modulates p53 activity towards pro-apoptotic transcription
Puca, R., Nardinocchi, L., Sacchi, A., Rechavi, G., Givol, D., & D'Orazi, G. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-85 · Cited by 93
Identification and Characterization of a Novel p300-mediated p53 Acetylation Site, Lysine 305
Wang, Y.-H., Tsay, Y.-G., Tan, B. C.-M., Lo, W.-Y., & Lee, S.-C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212574200 · Cited by 92
The PCAF acetylase complex as a potential tumor suppressor
Schiltz, R. L., & Nakatani, Y. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(99)00037-2 · Cited by 91
Rokudai, S., Aikawa, Y., Tagata, Y., Tsuchida, N., Taya, Y., & Kitabayashi, I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805101200 · Cited by 89
Sebti, S., Prébois, C., Pérez-Gracia, E., Bauvy, C., Desmots, F., Pirot, N., Gongora, C., Bach, A.-S., Hubberstey, A. V., Palissot, V., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313618111 · Cited by 88
Mahata, B., Sundqvist, A., & Xirodimas, D. P. (2011) · Oncogene · doi:10.1038/onc.2011.482 · Cited by 88
RNA content in the nucleolus alters p53 acetylation via MYBBP1A
Kuroda, T., Murayama, A., Katagiri, N., Ohta, Y., Fujita, E., Masumoto, H., Ema, M., Takahashi, S., Kimura, K., & Yanagisawa, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.23 · Cited by 88
Atkins, K. M., Thomas, L. L., Barroso-González, J., Thomas, L., Auclair, S., Yin, J., Kang, H., Chung, J. H., Dikeakos, J. D., & Thomas, G. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.049 · Cited by 87
MDM2 Inhibits PCAF (p300/CREB-binding Protein-associated Factor)-mediated p53 Acetylation
Jin, Y., Zeng, S. X., Dai, M.-S., Yang, X.-J., & Lu, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204078200 · Cited by 86
Lee, H., Sengupta, N., Villagra, A., Rezai-Zadeh, N., & Seto, E. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01971-05 · Cited by 86
Acetylation of the DNA Binding Domain Regulates Transcription-independent Apoptosis by p53
Sykes, S. M., Stanek, T. J., Frank, A., Murphy, M. E., & McMahon, S. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.026096 · Cited by 85
PML Activates Transcription by Protecting HIPK2 and p300 from SCFFbx3-Mediated Degradation
Shima, Y., Shima, T., Chiba, T., Irimura, T., Pandolfi, P. P., & Kitabayashi, I. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00897-08 · Cited by 84
Long, J., Jia, M.-Y., Fang, W.-Y., Chen, X.-J., Mu, L.-L., Wang, Z.-Y., Shen, Y., Xiang, R.-F., Wang, L.-N., Wang, L., et al. (2020) · Blood · doi:10.1182/blood.2019003538 · Cited by 84
Deubiquitination of Tip60 by USP7 determines the activity of the p53-dependent apoptotic pathway.
Dar, A., Shibata, E., & Dutta, A. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00358-13 · Cited by 83
Niegisch, G., Knievel, J., Koch, A., Hader, C., Fischer, U., Albers, P., & Schulz, W. A. (2012) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.06.015 · Cited by 82
HDAC6 deacetylates p53 at lysines 381/382 and differentially coordinates p53-induced apoptosis
Ryu, H.-W., Shin, D.-H., Lee, D. H., Choi, J., Han, G., Lee, K. Y., & Kwon, S. H. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.01.033 · Cited by 82
Brandl, A., Wagner, T., Uhlig, K. M., Knauer, S. K., Stauber, R. H., Melchior, F., Schneider, G., Heinzel, T., & Krämer, O. H. (2012) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjs013 · Cited by 81
Pro-Proliferative Function of Mitochondrial Sirtuin Deacetylase SIRT3 in Human Melanoma
George, J., Nihal, M., Singh, C. K., Zhong, W., Liu, X., & Ahmad, N. (2015) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2015.12.026 · Cited by 81
USP4 inhibits p53 and NF-κB through deubiquitinating and stabilizing HDAC2
Li, Z., Hao, Q., Luo, J., Xiong, J., Zhang, S., Wang, W., Bai, L., Wang, W., Chen, M., Wang, W., et al. (2015) · Oncogene · doi:10.1038/onc.2015.349 · Cited by 79
Adlakha, Y. K., & Saini, N. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.46 · Cited by 78
Stefano, V. D., Soddu, S., Sacchi, A., & D’Orazi, G. (2005) · Oncogene · doi:10.1038/sj.onc.1208717 · Cited by 78
Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphoma
Adams, H., Fritzsche, F. R., Dirnhofer, S., Kristiansen, G., & Tzankov, A. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728221003796609 · Cited by 78
Interferon Regulatory Factor 1 Binding to p300 Stimulates DNA-Dependent Acetylation of p53
Dornan, D., Eckert, M., Wallace, M., Shimizu, H., Ramsay, E., Hupp, T. R., & Ball, K. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.22.10083-10098.2004 · Cited by 77
HIPK2 restricts SIRT1 activity upon severe DNA damage by a phosphorylation-controlled mechanism
Conrad, E., Polonio-Vallon, T., Meister, M., Matt, S., Bitomsky, N., Herbel, C., Liebl, M., Greiner, V, Kriznik, B., Schumacher, S., et al. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.75 · Cited by 76
Guerardel, C., Deltour, S., Pinte, S., Monte, D., Begue, A., Godwin, A. K., & Leprince, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008690200 · Cited by 76
The acetyltransferase Tip60 contributes to mammary tumorigenesis by modulating DNA repair
Bassi, C., Li, Y.-T., Khu, K., Mateo, F., Baniasadi, P. S., Elia, A., Mason, J., Stambolic, V, Pujana, M. A., Mak, T. W., et al. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.173 · Cited by 76
SirT3 and p53 Deacetylation in Aging and Cancer
Chen, J., Wang, A., & Chen, Q. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25669 · Cited by 76
Xu, L., Chen, Y., Song, Q., Xu, D., Wang, Y., & Ma, D. (2009) · Neoplasia · doi:10.1593/neo.81524 · Cited by 75
Kong, R., Zhang, L., Hu, L., Peng, Q., Han, W., Du, X., & Ke, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.173393 · Cited by 74
ING5 Is a Tip60 Cofactor That Acetylates p53 in Response to DNA Damage
Liu, N., Wang, J., Wang, J., Wang, R., Liu, Z., Yu, Y., & Lü, H. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3684 · Cited by 74
Singh, M. K., Bacolla, A., Chaudhary, S., Hunt, C. R., Pandita, S., Chauhan, R., Gupta, A., Tainer, J. A., & Pandita, T. K. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00232-20 · Cited by 74
Autoacetylation of NAT10 is critical for its function in rRNA transcription activation
Cai, S., Liu, X., Zhang, C., Xing, B., & Du, X. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.092 · Cited by 73
The WTX Tumor Suppressor Enhances p53 Acetylation by CBP/p300
Kim, W. J., Rivera, M. N., Coffman, E. J., & Haber, D. A. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.12.025 · Cited by 72
Growth suppression of human carcinoma cells by reintroduction of the p300 coactivator
Suganuma, T., Kawabata, M., Ohshima, T., & Ikeda, M.-A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192586699 · Cited by 70
Li, D., Sun, X., Zhang, L., Yan, B., Xie, S., Liu, R., Liu, M., & Zhou, J. (2013) · Protein & Cell · doi:10.1007/s13238-013-0010-3 · Cited by 68
Li, Y., Li, Z., Dong, L., Tang, M., Zhang, P., Zhang, C., Cao, Z., Zhu, Q., Chen, Y., Wang, H., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky568 · Cited by 67
MDMX inhibits the p300/CBP-mediated acetylation of p53
Sabbatini, P., & McCormick, F. (2002) · DNA and Cell Biology · doi:10.1089/104454902320219077 · Cited by 62 · cited 1×
“MDMX, a homolog of MDM2, was found to inhibit the acetylation of p53 by p300/CBP [70].”
BackgroundMcCullough, C. E., & Marmorstein, R. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00841 · Cited by 61
mTOR inhibition acts as an unexpected checkpoint in p53-mediated tumor suppression
Kon, N., Ou, Y., Wang, S.-J., Li, H., Rustgi, A. K., & Gu, W. (2021) · Genes & Development · doi:10.1101/gad.340919.120 · Cited by 61
Özdağ, H., Batley, S. J., Försti, A., Iyer, N. G., Daigo, Y., Boutell, J., Arends, M. J., Ponder, B. A. J., Kouzarides, T., & Caldas, C. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600554 · Cited by 60
Deciphering the acetylation code of p53 in transcription regulation and tumor suppression
Xia, Z., Kon, N., Gu, A. P., Tavana, O., & Gu, W. (2022) · Oncogene · doi:10.1038/s41388-022-02331-9 · Cited by 60
Hua, W.-K., Qi, J., Cai, Q., Carnahan, E., Ayala Ramirez, M., Li, L., Marcucci, G., & Kuo, Y.-H. (2017) · Blood · doi:10.1182/blood-2017-03-771386 · Cited by 57
MDM2 Mediates p300/CREB-binding Protein-associated Factor Ubiquitination and Degradation
Jin, Y., Zeng, S. X., Lee, H., & Lu, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309916200 · Cited by 56
PIASy-mediated Tip60 sumoylation regulates p53-induced autophagy
Naidu, S. R., Lakhter, A. J., & Androphy, E. J. (2012) · Cell Cycle · doi:10.4161/cc.21091 · Cited by 56
Loss of BRG1 induces CRC cell senescence by regulating p53/p21 pathway
Wang, G., Fu, Y., Hu, F., Lan, J., Xu, F., Yang, X., Luo, X., Wang, J., & Hu, J. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.1 · Cited by 56
TSPYL2 is a novel regulator of SIRT1 and p300 activity in response to DNA damage
Magni, M., Buscemi, G., Maita, L., Peng, L., Chan, S. Y., Montecucco, A., Delia, D., & Zannini, L. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0168-6 · Cited by 56
Negative regulation of the p300-p53 interplay by DDX24
Shi, D., Dai, C., Qin, J., & Gu, W. (2016) · Oncogene · doi:10.1038/onc.2015.77 · Cited by 51
Giannini, R., & Cavallini, A. (2005) · PubMed · Cited by 51
Differential effects on p53-mediated cell cycle arrest vs. apoptosis by p90
Dai, C., Tang, Y., Jung, S. Y., Qin, J., Aaronson, S. A., & Gu, W. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110988108 · Cited by 50
Ma, Z., Li, Z., Wang, S., Zhou, Z., Liu, C., Zhuang, H., Zhou, Q., Huang, S., Zhang, C., & Hou, B. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02310-8 · Cited by 46
Ying, M., Wang, J., Li, D., Yu, G. Z., Wang, X., Pan, J., Chen, Y., & He, M. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.4.10748 · Cited by 45
SIRT3 deacetylates and promotes degradation of P53 in PTEN-defective non-small cell lung cancer
Xiong, Y., Wang, L., Wang, S., Wang, M., Zhao, J., Zhang, Z., Li, X., Jia, L., & Han, Y. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2537-9 · Cited by 44
Dai, C., Shi, D., & Gu, W. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.476606 · Cited by 43
A p53/lnc‐Ip53 Negative Feedback Loop Regulates Tumor Growth and Chemoresistance
Zhang, L., Yang, J., Luo, Y., Liu, F., Yuan, Y., & Zhuang, S. (2020) · Advanced Science · doi:10.1002/advs.202001364 · Cited by 43
The histone acetyltransferase hMOF suppresses hepatocellular carcinoma growth
Zhang, J., Liu, H., Pān, H., Yang, Y., Huang, G., Yang, Y., Zhou, W., & Pan, Z. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.122 · Cited by 42
Mazza, M., & Pelicci, P. G. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00174 · Cited by 37
Miyajima, C., Inoue, Y., & Hayashi, H. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00003 · Cited by 36
Self-citationOhshima, T., Suganuma, T., & Ikeda, M. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4389 · Cited by 36
Nuclear interactor of ARF and Mdm2 regulates multiple pathways to activate p53
Reed, S. M., Hagen, J., Tompkins, V. S., Thies, K., Quelle, F. W., & Quelle, D. E. (2014) · Cell Cycle · doi:10.4161/cc.28202 · Cited by 34
Grishina, I., Debus, K., García-Limones, C., Schneider, C., Shresta, A., García, C., Calzado, M. A., & Schmitz, M. L. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.09.011 · Cited by 33
Song, L., Gao, M., Dong, W., Hu, M., Li, J., Shi, X., Hao, Y., Li, Y., & Huang, C. (2010) · Oncogene · doi:10.1038/onc.2010.506 · Cited by 31
So, C.-K., Nie, Y., Song, Y., Yang, G., Chen, S., Wei, C. S.-J., Wang, L., Doggett, N. A., & Yang, C. S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0160 · Cited by 30
Suppression of p53 Activity through the Cooperative Action of Ski and Histone Deacetylase SIRT1
Inoue, Y., Iemura, S., Natsume, T., Miyazawa, K., & Imamura, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.177683 · Cited by 26
Self-citationMiyajima, C., Kawarada, Y., Inoue, Y., Suzuki, C., Mitamura, K., Morishita, D., Ohoka, N., Imamura, T., & Hayashi, H. (2020) · Cells · doi:10.3390/cells9010171 · Cited by 24
Self-citationNardilysin controls intestinal tumorigenesis through HDAC1/p53–dependent transcriptional regulation
Kanda, K., Sakamoto, J., Matsumoto, Y., Ikuta, K., Goto, N., Morita, Y., Ohno, M., Nishi, K., Eto, K., Kimura, Y., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.91316 · Cited by 17
Sinha, S., Malonia, S. K., Mittal, S. P. K., Mathai, J., Pal, J. K., & Chattopadhyay, S. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.10.020 · Cited by 16
The arsenal of TP53 mutants therapies: neoantigens and bispecific antibodies
Yang, C. Q., Lou, G., & Jin, W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00635-y · Cited by 16
Lee, H., Jung, T.-Y., Lim, S. H., Choi, E. J., Lee, J., & Min, D. S. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00659-y · Cited by 16
Tat-interactive Protein-60KDA (TIP60) Regulates the Tumorigenesis of Lung Cancer In Vitro
Yang, Y., Sun, J. H., Chen, T., Tao, Z., Zhang, X., Tian, F., Zhou, X., & Lu, D. (2017) · Journal of Cancer · doi:10.7150/jca.19677 · Cited by 15
Identification of New p53 Acetylation Sites in COS-1 Cells
Joubel, A., Chalkley, R. J., Medzihradszky, K. F., Hondermarck, H., & Burlingame, A. L. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800487-mcp200 · Cited by 14
Cited by
Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy
Song, B., Yang, P., & Zhang, S. (2024) · 癌症:英文版 · doi:10.1002/cac2.12520 · Cited by 107
Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies
Shen, J., Wang, Q., Mao, Y., Gao, W., & Duan, S. (2023) · MedComm · doi:10.1002/mco2.288 · Cited by 62
Kretová, M., Selicky, T., Čipáková, I., & Čipák, L. (2023) · Life · doi:10.3390/life13030604 · Cited by 46
Mechanisms of Interaction between Enhancers and Promoters in Three Drosophila Model Systems
Kyrchanova, O., Sokolov, V. V., & Georgiev, P. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032855 · Cited by 32
The role of lysine acetylation in metabolic sensing and proteostasis
Eftekhari, A., Sabir, U., & Kasumov, T. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108908 · Cited by 34
Metadata
- Authors
- Nagasaka, M., Miyajima, C., Aoki, H., Aoyama, M., Morishita, D., Inoue, Y., & Hayashi, H.
- Affiliations
- Nagoya City University (JP)
- Corresponding author
- Inoue, Yasumichi
- Hayashi, Hidetoshi
- ORCID
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2022-11-29
- Volume
- 11
- Issue
- 23
- Pages
- 3825
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC9737083
- OpenAlex
- W4310474581
- Cited by
- 45
- References
- 189
- Citations by year
- 2026: 12 · 2025: 16 · 2024: 10 · 2023: 7
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Grants-in-Aid for Scientific Research (C) (20K07052, 21H02650, 18K16081, 2021103, 2022005, 2221102, JPMJSP2130)
- Grant-in-Aid for Scientific Research (B) (20K07052, 21H02650, 18K16081, 2021103, 2022005, 2221102, JPMJSP2130)
- Grant-in-Aid for Young Scientists (20K07052, 21H02650, 18K16081, 2021103, 2022005, 2221102, JPMJSP2130)
- Grants-in-Aid for Research (20K07052, 21H02650, 18K16081, 2021103, 2022005, 2221102, JPMJSP2130)
- Japan Science and Technology Agency (JST) SPRING (20K07052, 21H02650, 18K16081, 2021103, 2022005, 2221102, JPMJSP2130)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Keywords
- p53, protein acetylation, acetyltransferase, deacetylase, post-translational modification, tumor suppressor, p53 target genes, cell fate determination
- MeSH terms
- Acetylation, Acetyltransferases, Protein Processing, Post-Translational, Transcription Factors, Tumor Suppressor Protein p53
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.